Pei-Ling Chen
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
-
- Developmental Biology and Gene Regulation 3
- Oncology 11
- CAR-T cell therapy research 6
- Cutaneous Melanoma Detection and Management 3
- Co-authors
- Thomas R. Clandinin (4 shared papers)Jennifer A. Wargo (4 shared papers)Patrick Hwu (1 shared paper)P. Andrew Futreal (1 shared paper)Hao Zhao (1 shared paper)Qiuming He (1 shared paper)Scott E. Woodman (1 shared paper)Chantale Bernatchez (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Neuron (2 papers)Modern Pathology (2 papers)Cell (2 papers)Journal of Materials Science (2 papers)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Pei-Ling Chen
47 papers receiving 2.0k citations
Pei-Ling Chen's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 907
- Immunology 629
- Cellular and Molecular Neuroscience 291
- Cancer Research 175
- Aging 20
Countries citing papers authored by Pei-Ling Chen
This map shows the geographic impact of Pei-Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei-Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei-Ling Chen more than expected).
Fields of papers citing papers by Pei-Ling Chen
This network shows the impact of papers produced by Pei-Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei-Ling Chen. The network helps show where Pei-Ling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei-Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy Hit paper breakdown → | 2016 | 953 |
| 2 | 2003 | 144 | |
| 3 | 2014 | 138 | |
| 4 | 2007 | 129 | |
| 5 | 2016 | 87 | |
| 6 | 2008 | 79 | |
| 7 | 2011 | 60 | |
| 8 | 2007 | 41 | |
| 9 | 2022 | 39 | |
| 10 | 2012 | 35 | |
| 11 | 2005 | 35 | |
| 12 | 2013 | 28 | |
| 13 | 2019 | 25 | |
| 14 | 2009 | 25 | |
| 15 | 2019 | 21 | |
| 16 | 2010 | 20 | |
| 17 | 2013 | 14 | |
| 18 | 2019 | 14 | |
| 19 | 2009 | 12 | |
| 20 | 2020 | 10 |
About Pei-Ling Chen
Pei-Ling Chen is a scholar working on Molecular Biology, Oncology, Immunology, Dermatology and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cutaneous lymphoproliferative disorders research (7 papers), CAR-T cell therapy research (6 papers), Systemic Lupus Erythematosus Research (5 papers), Immunotherapy and Immune Responses (5 papers), Neurobiology and Insect Physiology Research (5 papers), Cutaneous Melanoma Detection and Management (3 papers), T-cell and Retrovirus Studies (3 papers) and Developmental Biology and Gene Regulation (3 papers). The work is most often cited by research in Oncology (907 citations), Immunology (629 citations), Cellular and Molecular Neuroscience (291 citations), Cancer Research (175 citations) and Aging (20 citations). Pei-Ling Chen has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Thomas R. Clandinin, Jennifer A. Wargo, Patrick Hwu, P. Andrew Futreal, Hao Zhao, Qiuming He, Scott E. Woodman, Chantale Bernatchez, Padmanee Sharma and Jianjun Gao. Their work appears in journals such as Clinical Cancer Research, Neuron, Modern Pathology, Cell and Journal of Materials Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.